4,500
Views
17
CrossRef citations to date
0
Altmetric
Report

Brain pharmacokinetics of anti-transferrin receptor antibody affinity variants in rats determined using microdialysis

ORCID Icon, , , , , & ORCID Icon show all
Article: 1874121 | Received 02 Nov 2020, Accepted 06 Jan 2021, Published online: 26 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Habib Baghirov. (2023) Receptor-mediated transcytosis of macromolecules across the blood–brain barrier. Expert Opinion on Drug Delivery 0:0, pages 1-13.
Read now

Articles from other publishers (16)

Sho Sato, Siyu Liu, Akihiko Goto, Tomoki Yoneyama, Koki Okita, Syunsuke Yamamoto, Hideki Hirabayashi, Shinji Iwasaki & Hiroyuki Kusuhara. (2023) Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain. Journal of Controlled Release 357, pages 379-393.
Crossref
Maria A. Argiriadi, Kangwen Deng, David Egan, Lei Gao, Farid Gizatullin, John Harlan, Denise Karaoglu Hanzatian, Wei Qiu, Ruth Villanueva & Andrew Goodearl. (2023) The use of cyclic peptide antigens to generate LRP8 specific antibodies. Frontiers in Drug Discovery 2.
Crossref
Gillian Bonvicini, Stina Syvänen, Ken G. Andersson, Merja Haaparanta-Solin, Francisco López-Picón & Dag Sehlin. (2022) ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein. Translational Neurodegeneration 11:1.
Crossref
Katsuya Sakai, Nozomi Sugano-Nakamura, Emiko Mihara, Nichole Marcela Rojas-Chaverra, Sayako Watanabe, Hiroki Sato, Ryu Imamura, Dominic Chih-Cheng Voon, Itsuki Sakai, Chihiro Yamasaki, Chise Tateno, Mikihiro Shibata, Hiroaki Suga, Junichi Takagi & Kunio Matsumoto. (2022) Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions. Nature Biomedical Engineering 7:2, pages 164-176.
Crossref
Arthur J. Van De Vyver, Antje-Christine Walz, Mariette S. Heins, Afsaneh Abdolzade-Bavil, Thomas E. Kraft, Inja Waldhauer & Michael B. Otteneder. (2022) Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration. Frontiers in Pharmacology 13.
Crossref
Etienne Lessard, Kerry Rennie, Arsalan Haqqani, Binbing Ling, James Whitfield, Andrea Paradis, Joseph Araujo, Nathan Yoganathan, John Gillard, Danica Stanimirovic & Balu Chakravarthy. (2022) Pharmacokinetics and Pharmacodynamic Effect of a Blood-Brain Barrier-Crossing Fusion Protein Therapeutic for Alzheimer’s Disease in Rat and Dog. Pharmaceutical Research 39:7, pages 1497-1507.
Crossref
Kathryn Ball, Gerard Bruin, Enrique Escandón, Christoph Funk, Joao N.S. Pereira, Tong-Yuan Yang & Hongbin Yu. (2022) Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metabolism and Disposition 50:6, pages 858-866.
Crossref
Shufang Liu & Dhaval K. Shah. (2022) Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics. Drug Metabolism and Disposition 50:6, pages 867-878.
Crossref
Hsueh-Yuan Chang, Shengjia Wu, Ekram Ahmed Chowdhury & Dhaval K. Shah. (2022) Towards a translational physiologically-based pharmacokinetic (PBPK) model for receptor-mediated transcytosis of anti-transferrin receptor monoclonal antibodies in the central nervous system. Journal of Pharmacokinetics and Pharmacodynamics 49:3, pages 337-362.
Crossref
Hsueh-Yuan Chang, Shengjia Wu, Yingyi Li, Leiming Guo, Yuelin Li & Dhaval K. Shah. (2022) Effect of the Size of Protein Therapeutics on Brain Pharmacokinetics Following Systematic Administration. The AAPS Journal 24:3.
Crossref
Elizabeth C. M. de Lange & Margareta Hammarlund Udenaes. (2022) Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics. Clinical Pharmacology & Therapeutics 111:4, pages 758-773.
Crossref
Murad Al Gailani, Mengyang Liu & Jingyuan Wen. (2022) Ligands for oral delivery of peptides across the blood-brain-barrier. Acta Materia Medica 1:1.
Crossref
William M. Pardridge. (2021) Kinetics of Blood–Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor. Pharmaceuticals 15:1, pages 3.
Crossref
Aida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, Peisheng Hu, Alan L. Epstein & Leslie A. Khawli. (2021) Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives. International Journal of Molecular Sciences 22:12, pages 6442.
Crossref
William M. Pardridge & Tom Chou. (2021) Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor. Pharmaceuticals 14:6, pages 535.
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref